Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Assessor-blind, Randomized, Comparative, Pivotal Study to Evaluate the Efficacy and Safety of Wearable Visual Device (HMD)-VR-based Software Medical Device(OMNIFIT DTx-MDD) for Patients with Depressive Disorder

NCT05701345 is registered in ClinicalTrials.gov with Omni C&S as lead sponsor.

NCT NCT05701345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05701345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Assessor-blind, Randomized, Comparative, Pivotal Study to Evaluate the Efficacy and Safety of Wearable Visual Device (HMD)-VR-based Software Medical Device(OMNIFIT DTx-MDD) for Patients with Depressive Disorder
Lead sponsor
Omni C&S
Phase
Not applicable
Overall status
Completed
Start date
March 9, 2023
Completion date
November 1, 2024
Enrollment
162 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, depressive episode, major depressive disorder